Evidence map›Paper›PMID 29449630›Full record

ArticleScientific reports2018

Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response.

Jean-Louis Palgen, Nicolas Tchitchek, Jamila Elhmouzi-Younes, Simon Delandre, Inana Namet, Pierre Rosenbaum, Nathalie Dereuddre-Bosquet, Frédéric Martinon, Antonio Cosma, Yves Lévy and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jean-Louis PalgenCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Nicolas TchitchekCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Jamila Elhmouzi-YounesCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Simon DelandreCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Inana NametCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Pierre RosenbaumCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Nathalie Dereuddre-BosquetCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Frédéric MartinonCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Antonio CosmaCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.ORCID 0000-0002-3686-8034
Yves LévyVaccine Research Institute, Henri Mondor Hospital, 94010, Créteil, France.
Roger Le GrandCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France.
Anne-Sophie BeignonCEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT department, IBFJ, 92265, Fontenay-aux-Roses, France. anne-sophie.beignon@cea.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the innate immune response to vaccination is critical in vaccine design. Here, we studied blood innate myeloid cells after first and second immunization of cynomolgus macaques with the modified vaccinia virus Ankara. The inflammation at the injection site was moderate and resolved faster after the boost. The blood concentration of inflammation markers increased after both injections but was lower after the boost. The numbers of neutrophils, monocytes, and dendritic cells were transiently affected by vaccination, but without any major difference between prime and boost. However, phenotyping deeper those cells with mass cytometry unveiled their high phenotypic diversity with subsets responding differently after each injection, some enriched only after the primary injection and others only after the boost. Actually, the composition in subphenotype already differed just before the boost as compared to just before the prime. Multivariate analysis identified the key features that contributed to these differences. Cell subpopulations best characterizing the post-boost response were more activated, with a stronger expression of markers involved in phagocytosis, antigen presentation, costimulation, chemotaxis, and inflammation. This study revisits innate immunity by demonstrating that, like adaptive immunity, innate myeloid responses differ after one or two immunizations.

Indexed as

Adaptive ImmunityAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesGenetic VectorsImmunity, InnateImmunization, SecondaryInterferon-gammaInterleukin-2Macaca fascicularisMyeloid CellsMyeloid Progenitor CellsVaccinationVaccines, DNAVaccinia virusViral VaccinesInterferon-gammaInterleukin-2Vaccines, DNAViral Vaccines

Identifiers

PMID29449630
PMCPMC5814452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.